Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Becton Dickinson (ophthalmic drug)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

A portfolio of Indocyanine green ophthalmic drug for retina diagnostic imaging.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • 1 Becton Drive
  • Franklin Lakes, NJ 07417
  • United States

Becton Dickinson (ophthalmic drug) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Becton Dickinson (ophthalmic drug)‘s full profile, request access.

Request full access to PitchBook

Becton Dickinson (ophthalmic drug) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Becton Dickinson (ophthalmic drug)‘s full profile, request access.

Request full access to PitchBook